Alembic Limited

BSE: 506235 NSE: ALEMBICLTD
Alembic Limited - pharma in Baroda, Gujarat, India. FY 2026 financials & compliance.
CIN L26100GJ1907PLC000033 Incorporated 30 July 1907 ROC Ahmedabad HQ Baroda, Gujarat, India
Active Listed - NSE: ALEMBICLTD · BSE: 506235 Public Limited Company pharma
Data last updated
Market Cap
₹2,752 Cr
ALEMBICLTD · NSE
Share Price
₹106.53
-0.61% today
Revenue
₹240 Cr
FY 2025-26 · +16.7% YoY
EBITDA
₹90.47 Cr
Margin 37.7%
Net Profit
₹311 Cr
FY 2025-26 · +0.7% YoY
P/E (TTM)
8.5x
P/B 1.1x
ROE
5.3%
ROCE 6.2%
Debt / Equity
0.01
Interest cover 2.9x

About Alembic Limited

Data last updated: 26 September 2026

Alembic Limited is a public limited company based in Baroda, Gujarat, India, a subsidiary of Nirayu Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 30 July 1907, the company has been in operation for over 119 years.

Registered with ROC Ahmedabad under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD.

Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹51.36 Cr. Formerly known as Alembic Chemical Works Co Ltd. It is led by directors including Rati Desai and Chirayu Ramanbhai Amin.

Last AGM: 12 August 2025. Financial statements filed for year ended 31 March 2025. Office: Alembic Road, Baroda, Gujarat, India – 390003.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹239.99 Cr, a growth of 8.16% compared to the previous year. The net worth stands at ₹2,445.09 Cr (up 4.55% YoY). Total assets are valued at ₹2,472.94 Cr (up 4.43% YoY).

The company has a workforce of approximately 287 employees as per the latest available data. It operates as a subsidiary of Nirayu Limited. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Alembic Limited. As per MCA filings, the company has open charges of ₹67 Cr and satisfied charges of ₹446.2 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alembiclimited.com.

Company Details of Alembic Limited
CIN L26100GJ1907PLC000033
Registration Number 000033
Incorporation Date 30 July 1907
ROC Ahmedabad
Listing Status Listed (BSE: 506235, NSE: ALEMBICLTD)
Company Status Active
Date of Last AGM 12 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Nirayu Limited
Compliance Status Active Compliant
Key People
Udit Chirayu Amin Managing Director Rati Desai Director Chirayu Ramanbhai Amin Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    alembiclimited.com
  • Social Media
    Locked
  • Registered Address
    Alembic Road, Baroda, Gujarat, India – 390003
  • Industry
    Pharma, API Manufacturers
Company report
Alembic Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Alembic Limited report

Financials, compliance, directors, charges, ownership and filings for Alembic Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Alembic Limited

Alembic Limited has one previous CIN (Corporate Identification Number): U26100GJ1907PLC000033. The current CIN is L26100GJ1907PLC000033, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L26100GJ1907PLC000033 Current
U26100GJ1907PLC000033 Previous

Associated Brands with Alembic Limited

Alembic Limited operates one associated brand: Alembic Limited. These brands represent Alembic Limited's diversified market presence and brand portfolio.

Brand Description Website
Alembic Limited
Active pharmaceutical ingredients are manufactured by Alembic. alembiclimited.com

Competitors & Alternatives of Alembic Limited

Brands and companies operating in the same space as Alembic Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Alembic Limited

Alembic Limited is engaged in principal business activities including manufacturing and real estate, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, real estate activities with own or leased property. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
L Real Estate L1 Real estate activities with own or leased property Locked
Premium access

Business activity turnover details for Alembic Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Alembic Limited

Alembic Limited is audited by C N K & Associates LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
C N K & Associates LLP Locked Locked Locked
Premium access

Complete auditor history for Alembic Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Alembic Limited

Alembic Limited is currently managed by 8 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rati Desai
Also directs: Alembic Limited, Shiva Pharmachem Limited, Alembic City Limited
Director 13 Aug 2019 7 Years 1 Months Current
Chirayu Ramanbhai Amin
Also directs: Alembic Limited, Alembic Pharmaceuticals Limited, Paushak Limited and 4 more
Director 20 Aug 1967 59 Years 1 Months Current
Malika Chirayu Amin
Also directs: Alembic Limited, Whispering Mist Estate And Infra Private Limited, Eleventa Properties Private Limited and 4 more
Director 02 Jul 1988 38 Years 2 Months Current
Udit Chirayu Amin
Also directs: Alembic Limited, Paushak Limited, Shreno Limited and 2 more
Managing Director 28 Mar 2016 10 Years 5 Months Current
Sanjeev Virendra Shah
Also directs: Alembic Limited, Sterling Ferro Alloys Pvt Ltd
Director 07 Feb 2025 1 Years 7 Months Current
Mayurdhvaj Dilipsinh Jadeja
Also directs: Alembic Limited, Ratna Nico Chem Pvt Ltd
Director 07 Feb 2025 1 Years 7 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Alembic Limited FY 2025-26 filings available

Alembic Limited reported revenue of ₹239.99 Cr (up 8.16% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹240 Cr
+8.2% YoY
EBITDA
₹90.47 Cr
-3.5% YoY
Profit After Tax
₹311 Cr
+0.7% YoY
Net Worth
₹2,445 Cr
+4.6% YoY
Total Assets
₹2,473 Cr
+4.4% YoY
Total Debt
₹10.64 Cr
-26.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue24022215712778.2273.5273.93
Revenue growth+16.7%+27.4%+3.2%+51.7%+3.0%-11.6%-33.2%
EBITDA90.4793.7256.8629.7213.9211.063.28
EBITDA margin+37.7%+42.2%+36.1%+23.4%+17.8%+15.0%+4.4%
Profit before tax14915610386.7997.8517.0393.16
Net profit311309268198219339328
Net profit margin+129.8%+139.4%+170.0%+155.9%+279.9%+461.2%+443.2%
EPS (₹)12.3612.1010.467.428.6513.3512.82
Balance sheet
Total assets2,4732,3682,2082,0862,5042,3031,423
Net worth2,4452,3392,1862,0782,4972,2971,418
Total debt10.6414.459.150.000.000.280.00
Cash & bank3.294.372.471.901.856.5758.86
Net working capital3.3543.0837.4942.9249.7126.3663.32
Cash flow
Cash from operations12086.3722.6938.85(17.75)(2.18)6.54
Cash from investing(53.86)(26.58)25.847.3018.85(34.87)56.72
Cash from financing(67.50)(58.34)(48.19)(46.39)(5.82)(15.36)(6.41)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue48.7460.0474.3455.8649.7560.2757.9252.91
Revenue growth (YoY)-2.0%-0.4%+28.4%+5.6%-2.0%+22.9%+47.3%+63.9%
Other income5.962.142.3164.923.592.964.3765.60
EBITDA15.4620.2127.4423.2419.5927.3326.4019.58
EBITDA margin+31.7%+33.7%+36.9%+41.6%+39.4%+45.3%+45.6%+37.0%
Depreciation3.483.343.442.822.792.752.692.68
Interest0.600.570.550.560.590.620.690.67
Profit before tax17.3418.4425.7684.7819.8026.9227.3981.83
Tax1.648.833.298.722.003.171.304.52
Net profit15.709.6122.4776.0617.8023.7526.0977.31
EPS (₹)2.532.612.345.002.402.672.554.71
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue23221415212375.9772.3073.69
Revenue growth+15.6%+30.0%+0.3%+51.8%+2.4%-12.0%-33.8%
EBITDA87.7089.5656.2427.4012.9010.733.73
EBITDA margin+37.8%+41.8%+36.9%+22.3%+17.0%+14.8%+5.1%
Profit before tax14715210384.9997.2616.5293.69
Net profit11914192.0987.0382.599.6292.08
Net profit margin+51.3%+65.6%+60.5%+70.7%+108.7%+13.3%+125.0%
EPS (₹)4.855.533.623.093.340.523.64
Balance sheet
Total assets8468778268321,017832487
Net worth8218538098291,014827483
Total debt10.6414.459.150.000.000.280.00
Cash & bank2.974.192.191.791.596.4657.86
Net working capital5.5242.2535.2444.5049.7425.8263.57
Cash flow
Cash from operations11781.0325.3334.70(21.87)(1.12)5.48
Cash from investing(52.04)(21.79)22.6011.2922.66(35.15)56.79
Cash from financing(66.79)(57.70)(47.77)(46.08)(5.66)(15.27)(6.40)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue46.2757.7372.2854.0447.8958.2255.9751.10
Revenue growth (YoY)-3.4%-0.8%+29.1%+5.8%-2.4%+22.5%+47.5%+64.0%
Other income5.552.412.1064.803.462.784.2565.59
Total expenses32.2338.1845.2331.5229.3132.2130.2632.72
EBITDA14.0419.5527.0522.5218.5826.0125.7118.38
EBITDA margin+30.3%+33.9%+37.4%+41.7%+38.8%+44.7%+45.9%+36.0%
Depreciation3.383.253.342.722.702.662.592.59
Interest0.370.370.370.400.420.450.520.51
Profit before tax15.8418.3425.4484.2018.9225.6826.8580.87
Tax1.168.813.188.571.802.851.164.27

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 26 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue48.7460.0474.3455.8649.7560.2757.9252.91
Revenue growth (YoY)-2.0%-0.4%+28.4%+5.6%-2.0%+22.9%+47.3%+63.9%
Other income5.962.142.3164.923.592.964.3765.60
EBITDA15.4620.2127.4423.2419.5927.3326.4019.58
EBITDA margin+31.7%+33.7%+36.9%+41.6%+39.4%+45.3%+45.6%+37.0%
Depreciation3.483.343.442.822.792.752.692.68
Interest0.600.570.550.560.590.620.690.67
Profit before tax17.3418.4425.7684.7819.8026.9227.3981.83
Tax1.648.833.298.722.003.171.304.52
Net profit15.709.6122.4776.0617.8023.7526.0977.31
EPS (₹)2.532.612.345.002.402.672.554.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue24022215712778.2273.5273.93
Revenue growth+16.7%+27.4%+3.2%+51.7%+3.0%-11.6%-33.2%
Other income72.9774.8954.7764.2689.1810.2793.40
Total expenses15012810197.5264.3062.4670.65
Employee cost37.4427.3123.0324.0421.4722.6020.79
EBITDA90.4793.7256.8629.7213.9211.063.28
EBITDA margin+37.7%+42.2%+36.1%+23.4%+17.8%+15.0%+4.4%
Depreciation12.3910.637.846.724.863.943.23
Interest2.282.471.110.470.390.360.29
Profit before tax14915610386.7997.8517.0393.16
Tax22.8310.939.826.1811.663.200.13
Net profit311309268198219339328
Net profit margin+129.8%+139.4%+170.0%+155.9%+279.9%+461.2%+443.2%
EPS (₹)12.3612.1010.467.428.6513.3512.82
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital51.3651.3651.3651.3651.3651.3651.36
Reserves & surplus2,3942,2872,1342,0272,4452,2461,367
Shareholders' funds (net worth)2,4452,3392,1862,0782,4972,2971,418
Minority interest0.000.000.000.000.000.000.00
Secured loans10.6414.459.150.000.000.280.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt10.6414.459.150.000.000.280.00
Total liabilities2,4732,3682,2082,0862,5042,3031,423
Assets
Gross block535460410355324288244
Net block472409369321297265225
Capital work in progress1.500.001.100.130.195.843.08
Investments1,9741,9001,7861,7542,2082,0471,133
Inventories52.2499.3992.6088.6186.8754.2835.41
Sundry debtors31.9029.9719.7623.4515.2213.818.98
Cash & bank balances3.294.372.471.901.856.5758.86
Loans & advances13.1916.0411.2212.7713.5410.845.86
Total current assets10115012612711785.50109
Total current liabilities97.2710788.5683.8167.7759.1445.79
Net working capital3.3543.0837.4942.9249.7126.3663.32
Total assets2,4732,3682,2082,0862,5042,3031,423
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash2.711.260.931.175.8958.302.01
Net cash from operating activities12086.3722.6938.85(17.75)(2.18)6.54
Net cash from investing activities(53.86)(26.58)25.847.3018.85(34.87)56.72
Net cash from financing activities(67.50)(58.34)(48.19)(46.39)(5.82)(15.36)(6.41)
Net change in cash(1.30)1.450.33(0.24)(4.72)(52.41)56.85
Closing cash3.294.372.471.901.856.5758.86
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+8.2%+40.9%+23.8%+62.7%+6.4%-0.6%-40.3%
EBITDA growth-3.5%+64.8%+91.3%+113.5%+25.9%+237.2%-81.9%
PBT growth-4.3%+51.5%+18.3%-11.3%+474.6%-81.7%+108.6%
Net income growth+0.7%+15.5%+35.0%-9.4%-35.4%+3.5%+54.5%
Revenue CAGR (3Y)+23.6%+41.6%+28.9%+19.8%-14.2%-16.3%-20.5%
EBITDA CAGR (3Y)+44.9%+88.8%+72.6%+108.5%-8.3%-0.2%+53.3%
Profitability & leverage
Net income margin+52.5%+65.2%+59.0%+63.4%+110.2%+18.8%+125.8%
Return on capital employed+6.2%+6.9%+4.8%+3.8%+4.1%+0.7%+7.1%
Return on net worth+5.3%+6.4%+4.4%+3.5%+3.6%+0.5%+7.1%
Debt / equity0.010.010.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover2.922.972.262.044.305.06580.00
Efficiency & per share
Fixed asset turnover0.480.510.410.370.260.280.32
Inventory turnover3.172.311.741.451.111.642.09
Debtors turnover7.768.927.296.585.396.456.57
EPS (₹)12.3612.1010.467.428.6513.3512.82
Dividend per share (₹)2.402.402.402.201.800.200.60
Book value per share (₹)95.2291.0785.1180.9397.2389.4555.22
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue46.2757.7372.2854.0447.8958.2255.9751.10
Revenue growth (YoY)-3.4%-0.8%+29.1%+5.8%-2.4%+22.5%+47.5%+64.0%
Other income5.552.412.1064.803.462.784.2565.59
Total expenses32.2338.1845.2331.5229.3132.2130.2632.72
EBITDA14.0419.5527.0522.5218.5826.0125.7118.38
EBITDA margin+30.3%+33.9%+37.4%+41.7%+38.8%+44.7%+45.9%+36.0%
Depreciation3.383.253.342.722.702.662.592.59
Interest0.370.370.370.400.420.450.520.51
Profit before tax15.8418.3425.4484.2018.9225.6826.8580.87
Tax1.168.813.188.571.802.851.164.27
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue23221415212375.9772.3073.69
Revenue growth+15.6%+30.0%+0.3%+51.8%+2.4%-12.0%-33.8%
Other income72.7774.5154.6264.1189.099.9793.47
Total expenses14412596.0195.7663.0761.5769.96
Employee cost37.4427.3123.0324.0421.4722.6020.79
EBITDA87.7089.5656.2427.4012.9010.733.73
EBITDA margin+37.8%+41.8%+36.9%+22.3%+17.0%+14.8%+5.1%
Depreciation12.0110.247.466.364.503.913.23
Interest1.571.830.690.160.230.270.28
Profit before tax14715210384.9997.2616.5293.69
Tax22.3510.059.835.7311.573.150.13
Net profit11914192.0987.0382.599.6292.08
Net profit margin+51.3%+65.6%+60.5%+70.7%+108.7%+13.3%+125.0%
EPS (₹)4.855.533.623.093.340.523.64
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital51.3651.3651.3651.3651.3651.3651.36
Reserves & surplus770802757778962775432
Shareholders' funds (net worth)8218538098291,014827483
Secured loans10.6414.459.150.000.000.280.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt10.6414.459.150.000.000.280.00
Total liabilities8468778268321,017832487
Assets
Gross block531456406351321284244
Net block470406366318294261225
Capital work in progress1.500.001.100.130.195.843.08
Investments349414411503726581197
Inventories52.2499.3992.6088.6186.8754.2835.41
Sundry debtors30.2127.8917.4022.6814.9013.108.89
Cash & bank balances2.974.192.191.791.596.4657.86
Loans & advances12.3715.2810.4712.4613.2710.096.71
Total current assets97.7914712312611783.93109
Total current liabilities92.2710487.4281.0466.8958.1145.30
Net working capital5.5242.2535.2444.5049.7425.8263.57
Total assets8468778268321,017832487
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash2.530.990.830.925.7857.301.99
Net cash from operating activities11781.0325.3334.70(21.87)(1.12)5.48
Net cash from investing activities(52.04)(21.79)22.6011.2922.66(35.15)56.79
Net cash from financing activities(66.79)(57.70)(47.77)(46.08)(5.66)(15.27)(6.40)
Net change in cash(1.43)1.540.16(0.09)(4.86)(51.53)55.87
Closing cash2.974.192.191.791.596.4657.86
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+8.2%+40.8%+23.6%+62.1%+5.1%-1.9%-40.5%
EBITDA growth-2.1%+59.3%+105.3%+112.4%+20.2%+187.7%-79.4%
PBT growth-3.4%+48.0%+20.9%-12.6%+488.7%-82.4%+109.6%
Net income growth-15.5%+52.8%+5.8%+5.4%+758.5%-89.6%+130.1%
Revenue CAGR (3Y)+23.5%+41.3%+28.2%+18.7%-15.0%-16.8%-20.6%
EBITDA CAGR (3Y)+47.4%+90.8%+73.7%+94.4%-10.7%-1.2%+60.0%
Profitability & leverage
Net income margin+53.7%+66.2%+61.0%+64.4%+112.8%+18.5%+127.0%
Return on capital employed+17.2%+18.1%+12.5%+9.2%+10.6%+1.8%+20.8%
Return on net worth+14.9%+17.1%+11.3%+8.6%+9.3%+1.5%+20.9%
Debt / equity0.010.010.010.000.000.000.00
Long-term debt / equity0.010.010.000.000.000.000.00
Interest cover2.072.311.410.762.743.9656.00
Efficiency & per share
Fixed asset turnover0.470.500.400.370.250.270.31
Inventory turnover3.062.231.681.401.081.612.08
Debtors turnover7.989.477.606.555.436.586.58
EPS (₹)4.855.533.623.093.340.523.64
Dividend per share (₹)2.402.402.402.201.800.200.60
Book value per share (₹)31.9933.2331.5032.2839.4832.2018.81
Want more history and ratios?
You're viewing the latest exchange-filed financials for Alembic Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Alembic Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 70.90%, foreign institutional investors hold 1.20%, domestic institutional investors hold 0.10%, retail and other public shareholders hold 27.80% of Alembic Limited.

Promoters: 70.90%DII (Domestic Institutional): 0.10%FII (Foreign Institutional): 1.20%Retail & Others: 27.80%
Jun 2026
QUARTER
70.90% Promoters
0.10% DII (Domestic Institutional)
1.20% FII (Foreign Institutional)
27.80% Retail & Others
Promoter holding - history
Now 70.90% · Jun 2026High 70.90% · Sep 2025Low 70.90% · Sep 2025
69%69.8%70.5%71.3%72%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 70.90%Dec 2025: 70.90%Mar 2026: 70.90%Jun 2026: 70.90%70.90%70.90%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters70.90%70.90%70.90%70.90%
Public29.10%29.10%29.10%29.10%

Group Structure of Alembic Limited

Alembic Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Alembic Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Alembic City Limited U70100GJ1994PLC021552 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Alembic Limited

Open charges
₹67 Cr
Satisfied charges
₹446.2 Cr
Breakdown by lending institutions
Others₹67.00 Cr
Latest charge details
DateLenderAmountStatus
22 Sep 2023 Others ₹31 Cr Open
08 May 2006 Others ₹36 Cr Open
25 Sep 2009 Idbi Trusteeship Services Limited ₹25 Cr Satisfied
11 Aug 2009 Idbi Trusteeship Services Limited ₹25 Cr Satisfied
13 Sep 2007 Idbi Trusteeship Services Ltd ₹75 Cr Satisfied

Total charge records: 21 View all charges

Employees and EPFO Compliance at Alembic Limited

Alembic Limited has a workforce of 287 employees as of Apr 07, 2024.

Employee count
287
Active EPFO establishments
1
Employee growth
-4.65%
Premium access

Employee and EPFO history for Alembic Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Alembic Limited

Premium access

GST registrations and filing compliance for Alembic Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Alembic Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Alembic Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Alembic Limited

Premium access

MSME payment history for Alembic Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Alembic Limited

Premium access

Corporate group structure for Alembic Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Alembic Limited

Premium access

MCA filings and documents for Alembic Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Alembic Limited

Activity
12 Aug 2025
Alembic Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Alembic Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
08 Feb 2025
Jain Parkash was appointed as a Director on 08 Feb 2025 & has been associated with this company since 1 year 7 months.
Directors
07 Feb 2025
Sanjeev Virendra Shah was appointed as a Director on 07 Feb 2025 & has been associated with this company since 1 year 7 months.
Directors
07 Feb 2025
Mayurdhvaj Dilipsinh Jadeja was appointed as a Director on 07 Feb 2025 & has been associated with this company since 1 year 7 months.
Charges
22 Sep 2023
A charge with Others amounted to Rs. 31.00 Cr with Charge ID 100795632 was registered on 22 Sep 2023.

Recent News on Alembic Limited

Frequently Asked Questions about Alembic Limited

Alembic Limited is an active public limited company in the pharma sector based in Baroda, Gujarat, India. It was incorporated on 30 July 1907 (119+ years old) and is registered under CIN L26100GJ1907PLC000033. Listed on BSE: 506235 and NSE: ALEMBICLTD. The company has 287 employees.

Alembic Limited reported revenue of ₹239.99 Cr for FY 2025-26 (up 8.16% YoY) based on consolidated financials.

The current directors of Alembic Limited are:

The primary industry of Alembic Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Alembic Limited is listed on both BSE (code: 506235) and NSE (symbol: ALEMBICLTD).

Alembic Limited can be reached at the registered office: Alembic Road, Baroda, Gujarat, India – 390003, or through the website alembiclimited.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available